Analyze Diet
Journal of virology2007; 81(8); 3866-3876; doi: 10.1128/JVI.02075-06

Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression.

Abstract: Eastern equine encephalitis virus (EEEV) causes sporadic but often severe cases of human and equine neurological disease in North America. To determine how EEEV may evade innate immune responses, we screened individual EEEV proteins for the ability to rescue the growth of a Newcastle disease virus expressing green fluorescent protein (NDV-GFP) from the antiviral effects of interferon (IFN). Only expression of the EEEV capsid facilitated NDV-GFP replication. Inhibition of the antiviral effects of IFN by the capsid appears to occur through a general inhibition of cellular gene expression. For example, the capsid inhibited the expression of several reporter genes under the control of RNA polymerase II promoters. In contrast, capsid did not inhibit expression from a T7 RNA polymerase promoter construct, suggesting that the inhibition of gene expression is specific and is not a simple manifestation of toxicity. The inhibition correlated both with capsid-induced phosphorylation of eukaryotic initiation factor 2 alpha and with capsid-mediated inhibition of cellular mRNA accumulation. Mapping analysis identified the N terminus as the region important for the inhibition of host gene expression, suggesting that this inhibition is independent of capsid protease activity. Finally, when cell lines containing EEEV replicons encoding capsid were selected, replicons consistently acquired mutations that deleted all or part of the capsid, for example, amino acids 18 to 135. Given that the amino terminus of the capsid is required to inhibit host cell gene expression, these data suggest that capsid expression from the replicons is ultimately toxic to host cells, presumably because of its ability to inhibit gene expression.
Publication Date: 2007-01-31 PubMed ID: 17267491PubMed Central: PMC1866141DOI: 10.1128/JVI.02075-06Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Research Support
  • N.I.H.
  • Extramural
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research studied how the eastern equine encephalitis virus (EEEV) can avoid immune responses by inhibiting host cell gene expression via its capsid protein.

Introduction

  • The Eastern equine encephalitis virus (EEEV) is responsible for serious neurological diseases in humans and equines in North America. There are sporadic outbreaks of this virus and it’s therefore crucial to understand how it interacts with the host’s immune system.
  • The researchers were particularly interested in understanding how the EEEV might be bypassing the immune responses of the host.

Methodology

  • The researchers conducted a screening of individual EEEV proteins to see if they had the ability to counteract the antiviral effects of interferon (IFN), a protein the body produces in response to a viral infection.
  • They utilized a Newcastle disease virus expressing green fluorescent protein (NDV-GFP) in their assessment. By observing which EEEV proteins facilitated the replication of NDV-GFP, they could identify which were capable of outmanoeuvring the host’s defenses.
  • In this case, only the EEEV capsid was found to facilitate NDV-GFP replication.

Findings

  • The researchers found that the capsid inhibits the antiviral effects of IFN, seemingly due to a general inhibition of cellular gene expression.
  • The capsid of the EEEV was found to hamper the expression of different reporter genes, controlling RNA polymerase II promoters; in contrast it did not suppress the expression from a T7 RNA polymerase promoter construct, signaling that the inhibition is specific and not merely due to toxicity.
  • The inhibition of gene expression was linked to both the capsid-provoked phosphorylation of eukaryotic initiation factor 2 alpha and the capsid’s ability to reduce the accumulation of cellular mRNA.
  • The N terminus of the capsid was the key region for impeding host gene expression, suggesting that this inhibition is detached from capsid protease activity.
  • In various cell lines including EEEV replicons encoding capsid, replicons recurrently acquired mutations which deleted parts or the entirety of the capsid. This observation underlines that the capsid’s expression from the replicons is eventually harmful to host cells due to its capacity to inhibit gene expression.

Conclusion

  • The research reveals that the EEEV manages to shun the host immune response by inhibiting gene expression through its capsid protein, which could be key to understanding and combatting the disease caused by the virus.

Cite This Article

APA
Aguilar PV, Weaver SC, Basler CF. (2007). Capsid protein of eastern equine encephalitis virus inhibits host cell gene expression. J Virol, 81(8), 3866-3876. https://doi.org/10.1128/JVI.02075-06

Publication

ISSN: 0022-538X
NlmUniqueID: 0113724
Country: United States
Language: English
Volume: 81
Issue: 8
Pages: 3866-3876

Researcher Affiliations

Aguilar, Patricia V
  • Department of Microbiology, Box 1124, Mount Sinai School of Medicine, 1 Gustave L. Levy Place, New York, NY 10029, USA.
Weaver, Scott C
    Basler, Christopher F

      MeSH Terms

      • Capsid Proteins / immunology
      • Capsid Proteins / physiology
      • Cell Line
      • Chloramphenicol O-Acetyltransferase / analysis
      • Encephalitis Virus, Eastern Equine / immunology
      • Encephalitis Virus, Eastern Equine / physiology
      • Eukaryotic Initiation Factor-2 / metabolism
      • Gene Expression Regulation
      • Genes, Reporter
      • Green Fluorescent Proteins / analysis
      • Humans
      • Interferon-gamma / antagonists & inhibitors
      • Luciferases / analysis
      • Phosphorylation
      • Protein Structure, Tertiary
      • RNA, Messenger / biosynthesis
      • Virus Replication

      Grant Funding

      • U54 AI057158 / NIAID NIH HHS
      • AI057158 / NIAID NIH HHS

      References

      This article includes 75 references
      1. Aguilar PV, Paessler S, Carrara AS, Baron S, Poast J, Wang E, Moncayo AC, Anishchenko M, Watts D, Tesh RB, Weaver SC. Variation in interferon sensitivity and induction among strains of eastern equine encephalitis virus.. J Virol 2005 Sep;79(17):11300-10.
      2. Ahmed M, McKenzie MO, Puckett S, Hojnacki M, Poliquin L, Lyles DS. Ability of the matrix protein of vesicular stomatitis virus to suppress beta interferon gene expression is genetically correlated with the inhibition of host RNA and protein synthesis.. J Virol 2003 Apr;77(8):4646-57.
      3. Alcami A, Koszinowski UH. Viral mechanisms of immune evasion.. Immunol Today 2000 Sep;21(9):447-55.
      4. Anishchenko M, Paessler S, Greene IP, Aguilar PV, Carrara AS, Weaver SC. Generation and characterization of closely related epizootic and enzootic infectious cDNA clones for studying interferon sensitivity and emergence mechanisms of Venezuelan equine encephalitis virus.. J Virol 2004 Jan;78(1):1-8.
        pmc: PMC303380pubmed: 14671082doi: 10.1128/jvi.78.1.1-8.2004google scholar: lookup
      5. Basler CF, García-Sastre A. Viruses and the type I interferon antiviral system: induction and evasion.. Int Rev Immunol 2002 Jul-Oct;21(4-5):305-37.
        pubmed: 12486817doi: 10.1080/08830180213277google scholar: lookup
      6. Basler CF, Mikulasova A, Martinez-Sobrido L, Paragas J, Mühlberger E, Bray M, Klenk HD, Palese P, García-Sastre A. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3.. J Virol 2003 Jul;77(14):7945-56.
      7. Best SM, Morris KL, Shannon JG, Robertson SJ, Mitzel DN, Park GS, Boer E, Wolfinbarger JB, Bloom ME. Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist.. J Virol 2005 Oct;79(20):12828-39.
      8. Billecocq A, Spiegel M, Vialat P, Kohl A, Weber F, Bouloy M, Haller O. NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription.. J Virol 2004 Sep;78(18):9798-806.
      9. Breiman A, Grandvaux N, Lin R, Ottone C, Akira S, Yoneyama M, Fujita T, Hiscott J, Meurs EF. Inhibition of RIG-I-dependent signaling to the interferon pathway during hepatitis C virus expression and restoration of signaling by IKKepsilon.. J Virol 2005 Apr;79(7):3969-78.
      10. Bridgen A, Weber F, Fazakerley JK, Elliott RM. Bunyamwera bunyavirus nonstructural protein NSs is a nonessential gene product that contributes to viral pathogenesis.. Proc Natl Acad Sci U S A 2001 Jan 16;98(2):664-9.
        pmc: PMC14645pubmed: 11209062doi: 10.1073/pnas.98.2.664google scholar: lookup
      11. Cárdenas WB, Loo YM, Gale M Jr, Hartman AL, Kimberlin CR, Martínez-Sobrido L, Saphire EO, Basler CF. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling.. J Virol 2006 Jun;80(11):5168-78.
        pmc: PMC1472134pubmed: 16698997doi: 10.1128/jvi.02199-05google scholar: lookup
      12. Cebulla CM, Miller DM, Sedmak DD. Viral inhibition of interferon signal transduction.. Intervirology 1999;42(5-6):325-30.
        pubmed: 10702714doi: 10.1159/000053968google scholar: lookup
      13. Cheng G, Zhong J, Chisari FV. Inhibition of dsRNA-induced signaling in hepatitis C virus-infected cells by NS3 protease-dependent and -independent mechanisms.. Proc Natl Acad Sci U S A 2006 May 30;103(22):8499-504.
        pmc: PMC1482521pubmed: 16707574doi: 10.1073/pnas.0602957103google scholar: lookup
      14. Diamond MS, Harris E. Interferon inhibits dengue virus infection by preventing translation of viral RNA through a PKR-independent mechanism.. Virology 2001 Oct 25;289(2):297-311.
        pubmed: 11689052doi: 10.1006/viro.2001.1114google scholar: lookup
      15. Enninga J, Levy DE, Blobel G, Fontoura BM. Role of nucleoporin induction in releasing an mRNA nuclear export block.. Science 2002 Feb 22;295(5559):1523-5.
        pubmed: 11809937doi: 10.1126/science.1067861google scholar: lookup
      16. Favre D, Studer E, Michel MR. Semliki Forest virus capsid protein inhibits the initiation of translation by upregulating the double-stranded RNA-activated protein kinase (PKR).. Biosci Rep 1996 Dec;16(6):485-511.
        pubmed: 9062700doi: 10.1007/bf01198464google scholar: lookup
      17. Favre D, Studer E, Michel MR. Two nucleolar targeting signals present in the N-terminal part of Semliki Forest virus capsid protein.. Arch Virol 1994;137(1-2):149-55.
        pubmed: 7979988doi: 10.1007/bf01311181google scholar: lookup
      18. FEEMSTER RF, HAYMAKER W. [Eastern equine encephalitis].. Neurology 1958 Nov;8(11):882-3.
        pubmed: 13590404doi: 10.1212/wnl.8.11.882-bgoogle scholar: lookup
      19. Ferran MC, Lucas-Lenard JM. The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter.. J Virol 1997 Jan;71(1):371-7.
        pmc: PMC191060pubmed: 8985359doi: 10.1128/jvi.71.1.371-377.1997google scholar: lookup
      20. Foy E, Li K, Wang C, Sumpter R Jr, Ikeda M, Lemon SM, Gale M Jr. Regulation of interferon regulatory factor-3 by the hepatitis C virus serine protease.. Science 2003 May 16;300(5622):1145-8.
        pubmed: 12702807doi: 10.1126/science.1082604google scholar: lookup
      21. Frolov I, Agapov E, Hoffman TA Jr, Prágai BM, Lippa M, Schlesinger S, Rice CM. Selection of RNA replicons capable of persistent noncytopathic replication in mammalian cells.. J Virol 1999 May;73(5):3854-65.
      22. Frolova EI, Fayzulin RZ, Cook SH, Griffin DE, Rice CM, Frolov I. Roles of nonstructural protein nsP2 and Alpha/Beta interferons in determining the outcome of Sindbis virus infection.. J Virol 2002 Nov;76(22):11254-64.
      23. García-Sastre A. Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses.. Virology 2001 Jan 20;279(2):375-84.
        pubmed: 11162793doi: 10.1006/viro.2000.0756google scholar: lookup
      24. Garmashova N, Gorchakov R, Frolova E, Frolov I. Sindbis virus nonstructural protein nsP2 is cytotoxic and inhibits cellular transcription.. J Virol 2006 Jun;80(12):5686-96.
        pmc: PMC1472573pubmed: 16731907doi: 10.1128/jvi.02739-05google scholar: lookup
      25. Glanville N, Ulmanen I. Biological activity of in vitro synthesised protein: binding of Semliki Forest virus capsid protein to the large ribosomal subunit.. Biochem Biophys Res Commun 1976 Jul 12;71(1):393-9.
        pubmed: 962928doi: 10.1016/0006-291x(76)90295-3google scholar: lookup
      26. Goodbourn S, Didcock L, Randall RE. Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures.. J Gen Virol 2000 Oct;81(Pt 10):2341-2364.
        pubmed: 10993923doi: 10.1099/0022-1317-81-10-2341google scholar: lookup
      27. Gorchakov R, Frolova E, Frolov I. Inhibition of transcription and translation in Sindbis virus-infected cells.. J Virol 2005 Aug;79(15):9397-409.
      28. Gorchakov R, Frolova E, Williams BR, Rice CM, Frolov I. PKR-dependent and -independent mechanisms are involved in translational shutoff during Sindbis virus infection.. J Virol 2004 Aug;78(16):8455-67.
      29. Grandvaux N, tenOever BR, Servant MJ, Hiscott J. The interferon antiviral response: from viral invasion to evasion.. Curr Opin Infect Dis 2002 Jun;15(3):259-67.
      30. Grieder FB, Vogel SN. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection.. Virology 1999 Apr 25;257(1):106-18.
        pubmed: 10208925doi: 10.1006/viro.1999.9662google scholar: lookup
      31. Guo JT, Hayashi J, Seeger C. West Nile virus inhibits the signal transduction pathway of alpha interferon.. J Virol 2005 Feb;79(3):1343-50.
      32. Hartman AL, Dover JE, Towner JS, Nichol ST. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication.. J Virol 2006 Jul;80(13):6430-40.
        pmc: PMC1488969pubmed: 16775331doi: 10.1128/jvi.00044-06google scholar: lookup
      33. Hartman AL, Towner JS, Nichol ST. A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus.. Virology 2004 Oct 25;328(2):177-84.
        pubmed: 15464838doi: 10.1016/j.virol.2004.07.006google scholar: lookup
      34. Hiscott J, Lacoste J, Lin R. Recruitment of an interferon molecular signaling complex to the mitochondrial membrane: disruption by hepatitis C virus NS3-4A protease.. Biochem Pharmacol 2006 Nov 30;72(11):1477-84.
        pubmed: 16876765doi: 10.1016/j.bcp.2006.06.030google scholar: lookup
      35. Hong EM, Perera R, Kuhn RJ. Alphavirus capsid protein helix I controls a checkpoint in nucleocapsid core assembly.. J Virol 2006 Sep;80(18):8848-55.
        pmc: PMC1563918pubmed: 16940497doi: 10.1128/jvi.00619-06google scholar: lookup
      36. Ikegami T, Won S, Peters CJ, Makino S. Rescue of infectious rift valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene.. J Virol 2006 Mar;80(6):2933-40.
      37. Johnston, R. E., and C. J. Peters. 1996. Alphaviruses, p. 843-898. In D. M. Knipe, B. N. Fields, and P. M. Howley (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, PA.
      38. Jones M, Davidson A, Hibbert L, Gruenwald P, Schlaak J, Ball S, Foster GR, Jacobs M. Dengue virus inhibits alpha interferon signaling by reducing STAT2 expression.. J Virol 2005 May;79(9):5414-20.
      39. Kislauskis EH, Zhu X, Singer RH. beta-Actin messenger RNA localization and protein synthesis augment cell motility.. J Cell Biol 1997 Mar 24;136(6):1263-70.
        pmc: PMC2132521pubmed: 9087442doi: 10.1083/jcb.136.6.1263google scholar: lookup
      40. Lee S, Owen KE, Choi HK, Lee H, Lu G, Wengler G, Brown DT, Rossmann MG, Kuhn RJ. Identification of a protein binding site on the surface of the alphavirus nucleocapsid and its implication in virus assembly.. Structure 1996 May 15;4(5):531-41.
        pubmed: 8736552doi: 10.1016/s0969-2126(96)00059-7google scholar: lookup
      41. Le May N, Dubaele S, Proietti De Santis L, Billecocq A, Bouloy M, Egly JM. TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus.. Cell 2004 Feb 20;116(4):541-50.
        pubmed: 14980221doi: 10.1016/s0092-8674(04)00132-1google scholar: lookup
      42. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale M Jr, Lemon SM. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF.. Proc Natl Acad Sci U S A 2005 Feb 22;102(8):2992-7.
        pmc: PMC548795pubmed: 15710891doi: 10.1073/pnas.0408824102google scholar: lookup
      43. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.. Proc Natl Acad Sci U S A 2005 Dec 6;102(49):17717-22.
        pmc: PMC1308909pubmed: 16301520doi: 10.1073/pnas.0508531102google scholar: lookup
      44. Lin RJ, Chang BL, Yu HP, Liao CL, Lin YL. Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism.. J Virol 2006 Jun;80(12):5908-18.
        pmc: PMC1472572pubmed: 16731929doi: 10.1128/jvi.02714-05google scholar: lookup
      45. Lin RJ, Liao CL, Lin E, Lin YL. Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection.. J Virol 2004 Sep;78(17):9285-94.
      46. Linger BR, Kunovska L, Kuhn RJ, Golden BL. Sindbis virus nucleocapsid assembly: RNA folding promotes capsid protein dimerization.. RNA 2004 Jan;10(1):128-38.
        pmc: PMC1370524pubmed: 14681591doi: 10.1261/rna.5127104google scholar: lookup
      47. Liu WJ, Wang XJ, Mokhonov VV, Shi PY, Randall R, Khromykh AA. Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins.. J Virol 2005 Feb;79(3):1934-42.
      48. Loo YM, Owen DM, Li K, Erickson AK, Johnson CL, Fish PM, Carney DS, Wang T, Ishida H, Yoneyama M, Fujita T, Saito T, Lee WM, Hagedorn CH, Lau DT, Weinman SA, Lemon SM, Gale M Jr. Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection.. Proc Natl Acad Sci U S A 2006 Apr 11;103(15):6001-6.
        pmc: PMC1458687pubmed: 16585524doi: 10.1073/pnas.0601523103google scholar: lookup
      49. Lu Y, Wambach M, Katze MG, Krug RM. Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor.. Virology 1995 Dec 1;214(1):222-8.
        pubmed: 8525619doi: 10.1006/viro.1995.9937google scholar: lookup
      50. Muñoz-Jordán JL, Laurent-Rolle M, Ashour J, Martínez-Sobrido L, Ashok M, Lipkin WI, García-Sastre A. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses.. J Virol 2005 Jul;79(13):8004-13.
      51. Muñoz-Jordan JL, Sánchez-Burgos GG, Laurent-Rolle M, García-Sastre A. Inhibition of interferon signaling by dengue virus.. Proc Natl Acad Sci U S A 2003 Nov 25;100(24):14333-8.
        pmc: PMC283592pubmed: 14612562doi: 10.1073/pnas.2335168100google scholar: lookup
      52. Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector.. Gene 1991 Dec 15;108(2):193-9.
        pubmed: 1660837doi: 10.1016/0378-1119(91)90434-dgoogle scholar: lookup
      53. Noah DL, Twu KY, Krug RM. Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS.. Virology 2003 Mar 15;307(2):386-95.
        pubmed: 12667806doi: 10.1016/s0042-6822(02)00127-7google scholar: lookup
      54. Owen KE, Kuhn RJ. Alphavirus budding is dependent on the interaction between the nucleocapsid and hydrophobic amino acids on the cytoplasmic domain of the E2 envelope glycoprotein.. Virology 1997 Apr 14;230(2):187-96.
        pubmed: 9143274doi: 10.1006/viro.1997.8480google scholar: lookup
      55. Park MS, Shaw ML, Muñoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, García-Sastre A, Basler CF. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins.. J Virol 2003 Jan;77(2):1501-11.
      56. Perera R, Owen KE, Tellinghuisen TL, Gorbalenya AE, Kuhn RJ. Alphavirus nucleocapsid protein contains a putative coiled coil alpha-helix important for core assembly.. J Virol 2001 Jan;75(1):1-10.
        pmc: PMC113891pubmed: 11119567doi: 10.1128/jvi.75.1.1-10.2001google scholar: lookup
      57. Petrakova O, Volkova E, Gorchakov R, Paessler S, Kinney RM, Frolov I. Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in Mammalian cells.. J Virol 2005 Jun;79(12):7597-608.
      58. Raju R, Kolakofsky D. La Crosse virus infection of mammalian cells induces mRNA instability.. J Virol 1988 Jan;62(1):27-32.
        pmc: PMC250497pubmed: 3334745doi: 10.1128/jvi.62.1.27-32.1988google scholar: lookup
      59. Reid SP, Leung LW, Hartman AL, Martinez O, Shaw ML, Carbonnelle C, Volchkov VE, Nichol ST, Basler CF. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation.. J Virol 2006 Jun;80(11):5156-67.
        pmc: PMC1472181pubmed: 16698996doi: 10.1128/jvi.02349-05google scholar: lookup
      60. Ryman KD, Meier KC, Nangle EM, Ragsdale SL, Korneeva NL, Rhoads RE, MacDonald MR, Klimstra WB. Sindbis virus translation is inhibited by a PKR/RNase L-independent effector induced by alpha/beta interferon priming of dendritic cells.. J Virol 2005 Feb;79(3):1487-99.
      61. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed., vol. 3. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
      62. Singh I, Helenius A. Role of ribosomes in Semliki Forest virus nucleocapsid uncoating.. J Virol 1992 Dec;66(12):7049-58.
      63. Söderlund H. Kinetics of formation of the Semliki Forest virus nucleocapsid.. Intervirology 1973;1(5-6):354-61.
        pubmed: 4785173doi: 10.1159/000148864google scholar: lookup
      64. Söderlund H, Ulmanen I. Transient association of Semliki Forest virus capsid protein with ribosomes.. J Virol 1977 Dec;24(3):907-9.
        pmc: PMC516013pubmed: 592469doi: 10.1128/jvi.24.3.907-909.1977google scholar: lookup
      65. Strauss JH, Strauss EG. The alphaviruses: gene expression, replication, and evolution.. Microbiol Rev 1994 Sep;58(3):491-562.
        pmc: PMC372977pubmed: 7968923doi: 10.1128/mr.58.3.491-562.1994google scholar: lookup
      66. Talon J, Horvath CM, Polley R, Basler CF, Muster T, Palese P, García-Sastre A. Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein.. J Virol 2000 Sep;74(17):7989-96.
      67. Talon J, Salvatore M, O'Neill RE, Nakaya Y, Zheng H, Muster T, García-Sastre A, Palese P. Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach.. Proc Natl Acad Sci U S A 2000 Apr 11;97(8):4309-14.
        pmc: PMC18238pubmed: 10725408doi: 10.1073/pnas.070525997google scholar: lookup
      68. Tellinghuisen TL, Hamburger AE, Fisher BR, Ostendorp R, Kuhn RJ. In vitro assembly of alphavirus cores by using nucleocapsid protein expressed in Escherichia coli.. J Virol 1999 Jul;73(7):5309-19.
      69. Tellinghuisen TL, Perera R, Kuhn RJ. In vitro assembly of Sindbis virus core-like particles from cross-linked dimers of truncated and mutant capsid proteins.. J Virol 2001 Mar;75(6):2810-7.
      70. Thomas D, Blakqori G, Wagner V, Banholzer M, Kessler N, Elliott RM, Haller O, Weber F. Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist.. J Biol Chem 2004 Jul 23;279(30):31471-7.
        pubmed: 15150262doi: 10.1074/jbc.m400938200google scholar: lookup
      71. Trgovcich J, Aronson JF, Eldridge JC, Johnston RE. TNFalpha, interferon, and stress response induction as a function of age-related susceptibility to fatal Sindbis virus infection of mice.. Virology 1999 Oct 25;263(2):339-48.
        pubmed: 10544107doi: 10.1006/viro.1999.9913google scholar: lookup
      72. Ulmanen I, Söderlund H, Kääriäinen L. Semliki Forest virus capsid protein associates with the 60S ribosomal subunit in infected cells.. J Virol 1976 Oct;20(1):203-10.
        pmc: PMC354981pubmed: 824460doi: 10.1128/jvi.20.1.203-210.1976google scholar: lookup
      73. White LJ, Wang JG, Davis NL, Johnston RE. Role of alpha/beta interferon in Venezuelan equine encephalitis virus pathogenesis: effect of an attenuating mutation in the 5' untranslated region.. J Virol 2001 Apr;75(8):3706-18.
      74. Yoshida T, Shaw MW, Young JF, Compans RW. Characterization of the RNA associated with influenza A cytoplasmic inclusions and the interaction of NS1 protein with RNA.. Virology 1981 Apr 15;110(1):87-97.
        pubmed: 6163252doi: 10.1016/0042-6822(81)90010-6google scholar: lookup
      75. Yuen T, Wurmbach E, Pfeffer RL, Ebersole BJ, Sealfon SC. Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays.. Nucleic Acids Res 2002 May 15;30(10):e48.
        pmc: PMC115302pubmed: 12000853doi: 10.1093/nar/30.10.e48google scholar: lookup

      Citations

      This article has been cited 53 times.
      1. Jungfleisch J, Böttcher R, Talló-Parra M, Pérez-Vilaró G, Merits A, Novoa EM, Díez J. CHIKV infection reprograms codon optimality to favor viral RNA translation by altering the tRNA epitranscriptome.. Nat Commun 2022 Aug 11;13(1):4725.
        doi: 10.1038/s41467-022-31835-xpubmed: 35953468google scholar: lookup
      2. Su C, Ding K, Xu J, Wu J, Liu J, Shen J, Zhou H, Liu H. Preparation and application of chikungunya pseudovirus containing double reporter genes.. Sci Rep 2022 Jun 14;12(1):9844.
        doi: 10.1038/s41598-022-13230-0pubmed: 35701460google scholar: lookup
      3. Singh A, Kumar A, Uversky VN, Giri R. Understanding the interactability of chikungunya virus proteins via molecular recognition feature analysis.. RSC Adv 2018 Jul 30;8(48):27293-27303.
        doi: 10.1039/c8ra04760jpubmed: 35539973google scholar: lookup
      4. Zhang YN, Zhang ZR, Li N, Pei XR, Li XD, Deng CL, Ye HQ, Zhang B. High-Titer Self-Propagating Capsidless Chikungunya Virus Generated in Vero Cells as a Strategy for Alphavirus Vaccine Development.. J Virol 2022 Mar 23;96(6):e0148021.
        doi: 10.1128/JVI.01480-21pubmed: 35107379google scholar: lookup
      5. Meshram CD, Shiliaev N, Frolova EI, Frolov I. Hypervariable Domain of nsP3 of Eastern Equine Encephalitis Virus Is a Critical Determinant of Viral Virulence.. J Virol 2020 Aug 17;94(17).
        doi: 10.1128/JVI.00617-20pubmed: 32581106google scholar: lookup
      6. Rogers KJ, Jones-Burrage S, Maury W, Mukhopadhyay S. TF protein of Sindbis virus antagonizes host type I interferon responses in a palmitoylation-dependent manner.. Virology 2020 Mar;542:63-70.
        doi: 10.1016/j.virol.2020.01.001pubmed: 32056669google scholar: lookup
      7. Liu X, Mutso M, Cherkashchenko L, Zusinaite E, Herrero LJ, Doggett SL, Haniotis J, Merits A, Herring BL, Taylor A, Mahalingam S. Identification of Natural Molecular Determinants of Ross River Virus Type I Interferon Modulation.. J Virol 2020 Mar 31;94(8).
        doi: 10.1128/JVI.01788-19pubmed: 31996431google scholar: lookup
      8. Bhalla N, Gardner CL, Downs SN, Dunn M, Sun C, Klimstra WB. Macromolecular Synthesis Shutoff Resistance by Myeloid Cells Is Critical to IRF7-Dependent Systemic Interferon Alpha/Beta Induction after Alphavirus Infection.. J Virol 2019 Dec 15;93(24).
        doi: 10.1128/JVI.00872-19pubmed: 31578290google scholar: lookup
      9. Zhang YN, Deng CL, Li JQ, Li N, Zhang QY, Ye HQ, Yuan ZM, Zhang B. Infectious Chikungunya Virus (CHIKV) with a Complete Capsid Deletion: a New Approach for a CHIKV Vaccine.. J Virol 2019 Aug 1;93(15).
        doi: 10.1128/JVI.00504-19pubmed: 31092567google scholar: lookup
      10. Trobaugh DW, Sun C, Dunn MD, Reed DS, Klimstra WB. Rational design of a live-attenuated eastern equine encephalitis virus vaccine through informed mutation of virulence determinants.. PLoS Pathog 2019 Feb;15(2):e1007584.
        doi: 10.1371/journal.ppat.1007584pubmed: 30742691google scholar: lookup
      11. Liu X, Mutso M, Utt A, Lepland A, Herrero LJ, Taylor A, Bettadapura J, Rudd PA, Merits A, Mahalingam S. Decreased Virulence of Ross River Virus Harboring a Mutation in the First Cleavage Site of Nonstructural Polyprotein Is Caused by a Novel Mechanism Leading to Increased Production of Interferon-Inducing RNAs.. mBio 2018 Aug 21;9(4).
        doi: 10.1128/mBio.00044-18pubmed: 30131356google scholar: lookup
      12. Dupuy LC, Richards MJ, Livingston BD, Hannaman D, Schmaljohn CS. A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges.. J Immunol Res 2018;2018:8521060.
        doi: 10.1155/2018/8521060pubmed: 29967804google scholar: lookup
      13. Lundberg L, Carey B, Kehn-Hall K. Venezuelan Equine Encephalitis Virus Capsid-The Clever Caper.. Viruses 2017 Sep 29;9(10).
        doi: 10.3390/v9100279pubmed: 28961161google scholar: lookup
      14. Trobaugh DW, Klimstra WB. Alphaviruses suppress host immunity by preventing myeloid cell replication and antagonizing innate immune responses.. Curr Opin Virol 2017 Apr;23:30-34.
        doi: 10.1016/j.coviro.2017.02.004pubmed: 28288385google scholar: lookup
      15. Taylor A, Liu X, Zaid A, Goh LY, Hobson-Peters J, Hall RA, Merits A, Mahalingam S. Mutation of the N-Terminal Region of Chikungunya Virus Capsid Protein: Implications for Vaccine Design.. mBio 2017 Feb 21;8(1).
        doi: 10.1128/mBio.01970-16pubmed: 28223458google scholar: lookup
      16. Lundberg L, Pinkham C, de la Fuente C, Brahms A, Shafagati N, Wagstaff KM, Jans DA, Tamir S, Kehn-Hall K. Selective Inhibitor of Nuclear Export (SINE) Compounds Alter New World Alphavirus Capsid Localization and Reduce Viral Replication in Mammalian Cells.. PLoS Negl Trop Dis 2016 Nov;10(11):e0005122.
        doi: 10.1371/journal.pntd.0005122pubmed: 27902702google scholar: lookup
      17. Bhalla N, Sun C, Metthew Lam LK, Gardner CL, Ryman KD, Klimstra WB. Host translation shutoff mediated by non-structural protein 2 is a critical factor in the antiviral state resistance of Venezuelan equine encephalitis virus.. Virology 2016 Sep;496:147-165.
        doi: 10.1016/j.virol.2016.06.005pubmed: 27318152google scholar: lookup
      18. Goh LY, Hobson-Peters J, Prow NA, Baker K, Piyasena TB, Taylor CT, Rana A, Hastie ML, Gorman JJ, Hall RA. The Chikungunya Virus Capsid Protein Contains Linear B Cell Epitopes in the N- and C-Terminal Regions that are Dependent on an Intact C-Terminus for Antibody Recognition.. Viruses 2015 Jun 8;7(6):2943-64.
        doi: 10.3390/v7062754pubmed: 26061335google scholar: lookup
      19. Santiago FW, Covaleda LM, Sanchez-Aparicio MT, Silvas JA, Diaz-Vizarreta AC, Patel JR, Popov V, Yu XJ, García-Sastre A, Aguilar PV. Hijacking of RIG-I signaling proteins into virus-induced cytoplasmic structures correlates with the inhibition of type I interferon responses.. J Virol 2014 Apr;88(8):4572-85.
        doi: 10.1128/JVI.03021-13pubmed: 24478431google scholar: lookup
      20. Ni P, Cheng Kao C. Non-encapsidation activities of the capsid proteins of positive-strand RNA viruses.. Virology 2013 Nov;446(1-2):123-32.
        doi: 10.1016/j.virol.2013.07.023pubmed: 24074574google scholar: lookup
      21. Guerbois M, Volkova E, Forrester NL, Rossi SL, Frolov I, Weaver SC. IRES-driven expression of the capsid protein of the Venezuelan equine encephalitis virus TC-83 vaccine strain increases its attenuation and safety.. PLoS Negl Trop Dis 2013;7(5):e2197.
        doi: 10.1371/journal.pntd.0002197pubmed: 23675542google scholar: lookup
      22. Peltier DC, Lazear HM, Farmer JR, Diamond MS, Miller DJ. Neurotropic arboviruses induce interferon regulatory factor 3-mediated neuronal responses that are cytoprotective, interferon independent, and inhibited by Western equine encephalitis virus capsid.. J Virol 2013 Feb;87(3):1821-33.
        doi: 10.1128/JVI.02858-12pubmed: 23192868google scholar: lookup
      23. Wollish AC, Ferris MT, Blevins LK, Loo YM, Gale M Jr, Heise MT. An attenuating mutation in a neurovirulent Sindbis virus strain interacts with the IPS-1 signaling pathway in vivo.. Virology 2013 Jan 20;435(2):269-80.
        doi: 10.1016/j.virol.2012.09.008pubmed: 23084425google scholar: lookup
      24. Atasheva S, Akhrymuk M, Frolova EI, Frolov I. New PARP gene with an anti-alphavirus function.. J Virol 2012 Aug;86(15):8147-60.
        doi: 10.1128/JVI.00733-12pubmed: 22623789google scholar: lookup
      25. Clavarino G, Cláudio N, Couderc T, Dalet A, Judith D, Camosseto V, Schmidt EK, Wenger T, Lecuit M, Gatti E, Pierre P. Induction of GADD34 is necessary for dsRNA-dependent interferon-β production and participates in the control of Chikungunya virus infection.. PLoS Pathog 2012;8(5):e1002708.
        doi: 10.1371/journal.ppat.1002708pubmed: 22615568google scholar: lookup
      26. Weaver SC, Winegar R, Manger ID, Forrester NL. Alphaviruses: population genetics and determinants of emergence.. Antiviral Res 2012 Jun;94(3):242-57.
      27. Frolov I, Akhrymuk M, Akhrymuk I, Atasheva S, Frolova EI. Early events in alphavirus replication determine the outcome of infection.. J Virol 2012 May;86(9):5055-66.
        doi: 10.1128/JVI.07223-11pubmed: 22345447google scholar: lookup
      28. Hollidge BS, Weiss SR, Soldan SS. The role of interferon antagonist, non-structural proteins in the pathogenesis and emergence of arboviruses.. Viruses 2011 Jun;3(6):629-58.
        doi: 10.3390/v3060629pubmed: 21994750google scholar: lookup
      29. Metz SW, Feenstra F, Villoing S, van Hulten MC, van Lent JW, Koumans J, Vlak JM, Pijlman GP. Low temperature-dependent salmonid alphavirus glycoprotein processing and recombinant virus-like particle formation.. PLoS One 2011;6(10):e25816.
        doi: 10.1371/journal.pone.0025816pubmed: 21991361google scholar: lookup
      30. Dupuy LC, Richards MJ, Ellefsen B, Chau L, Luxembourg A, Hannaman D, Livingston BD, Schmaljohn CS. A DNA vaccine for venezuelan equine encephalitis virus delivered by intramuscular electroporation elicits high levels of neutralizing antibodies in multiple animal models and provides protective immunity to mice and nonhuman primates.. Clin Vaccine Immunol 2011 May;18(5):707-16.
        doi: 10.1128/CVI.00030-11pubmed: 21450977google scholar: lookup
      31. Lidbury BA, Rulli NE, Musso CM, Cossetto SB, Zaid A, Suhrbier A, Rothenfluh HS, Rolph MS, Mahalingam S. Identification and characterization of a ross river virus variant that grows persistently in macrophages, shows altered disease kinetics in a mouse model, and exhibits resistance to type I interferon.. J Virol 2011 Jun;85(11):5651-63.
        doi: 10.1128/JVI.01189-10pubmed: 21430046google scholar: lookup
      32. Kim DY, Atasheva S, Foy NJ, Wang E, Frolova EI, Weaver S, Frolov I. Design of chimeric alphaviruses with a programmed, attenuated, cell type-restricted phenotype.. J Virol 2011 May;85(9):4363-76.
        doi: 10.1128/JVI.00065-11pubmed: 21345954google scholar: lookup
      33. White LK, Sali T, Alvarado D, Gatti E, Pierre P, Streblow D, Defilippis VR. Chikungunya virus induces IPS-1-dependent innate immune activation and protein kinase R-independent translational shutoff.. J Virol 2011 Jan;85(1):606-20.
        doi: 10.1128/JVI.00767-10pubmed: 20962078google scholar: lookup
      34. Ramasamy S, Liu CQ, Tran H, Gubala A, Gauci P, McAllister J, Vo T. Principles of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agents.. Br J Pharmacol 2010 Oct;161(4):721-48.
      35. Simmons JD, Wollish AC, Heise MT. A determinant of Sindbis virus neurovirulence enables efficient disruption of Jak/STAT signaling.. J Virol 2010 Nov;84(21):11429-39.
        doi: 10.1128/JVI.00577-10pubmed: 20739538google scholar: lookup
      36. Fros JJ, Liu WJ, Prow NA, Geertsema C, Ligtenberg M, Vanlandingham DL, Schnettler E, Vlak JM, Suhrbier A, Khromykh AA, Pijlman GP. Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling.. J Virol 2010 Oct;84(20):10877-87.
        doi: 10.1128/JVI.00949-10pubmed: 20686047google scholar: lookup
      37. Atasheva S, Krendelchtchikova V, Liopo A, Frolova E, Frolov I. Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein.. J Virol 2010 Oct;84(19):10004-15.
        doi: 10.1128/JVI.01151-10pubmed: 20668087google scholar: lookup
      38. Xu C, Guo TC, Mutoloki S, Haugland Ø, Marjara IS, Evensen Ø. Alpha interferon and not gamma interferon inhibits salmonid alphavirus subtype 3 replication in vitro.. J Virol 2010 Sep;84(17):8903-12.
        doi: 10.1128/JVI.00851-10pubmed: 20573808google scholar: lookup
      39. Burke CW, Gardner CL, Steffan JJ, Ryman KD, Klimstra WB. Characteristics of alpha/beta interferon induction after infection of murine fibroblasts with wild-type and mutant alphaviruses.. Virology 2009 Dec 5;395(1):121-32.
        doi: 10.1016/j.virol.2009.08.039pubmed: 19782381google scholar: lookup
      40. Jose J, Snyder JE, Kuhn RJ. A structural and functional perspective of alphavirus replication and assembly.. Future Microbiol 2009 Sep;4(7):837-56.
        doi: 10.2217/fmb.09.59pubmed: 19722838google scholar: lookup
      41. Simmons JD, White LJ, Morrison TE, Montgomery SA, Whitmore AC, Johnston RE, Heise MT. Venezuelan equine encephalitis virus disrupts STAT1 signaling by distinct mechanisms independent of host shutoff.. J Virol 2009 Oct;83(20):10571-81.
        doi: 10.1128/JVI.01041-09pubmed: 19656875google scholar: lookup
      42. Yin J, Gardner CL, Burke CW, Ryman KD, Klimstra WB. Similarities and differences in antagonism of neuron alpha/beta interferon responses by Venezuelan equine encephalitis and Sindbis alphaviruses.. J Virol 2009 Oct;83(19):10036-47.
        doi: 10.1128/JVI.01209-09pubmed: 19641001google scholar: lookup
      43. Gardner CL, Yin J, Burke CW, Klimstra WB, Ryman KD. Type I interferon induction is correlated with attenuation of a South American eastern equine encephalitis virus strain in mice.. Virology 2009 Aug 1;390(2):338-47.
        doi: 10.1016/j.virol.2009.05.030pubmed: 19539968google scholar: lookup
      44. Attarzadeh-Yazdi G, Fragkoudis R, Chi Y, Siu RW, Ulper L, Barry G, Rodriguez-Andres J, Nash AA, Bouloy M, Merits A, Fazakerley JK, Kohl A. Cell-to-cell spread of the RNA interference response suppresses Semliki Forest virus (SFV) infection of mosquito cell cultures and cannot be antagonized by SFV.. J Virol 2009 Jun;83(11):5735-48.
        doi: 10.1128/JVI.02440-08pubmed: 19297476google scholar: lookup
      45. Fragkoudis R, Chi Y, Siu RW, Barry G, Attarzadeh-Yazdi G, Merits A, Nash AA, Fazakerley JK, Kohl A. Semliki Forest virus strongly reduces mosquito host defence signaling.. Insect Mol Biol 2008 Dec;17(6):647-56.
      46. Gardner CL, Burke CW, Tesfay MZ, Glass PJ, Klimstra WB, Ryman KD. Eastern and Venezuelan equine encephalitis viruses differ in their ability to infect dendritic cells and macrophages: impact of altered cell tropism on pathogenesis.. J Virol 2008 Nov;82(21):10634-46.
        doi: 10.1128/JVI.01323-08pubmed: 18768986google scholar: lookup
      47. Wang E, Volkova E, Adams AP, Forrester N, Xiao SY, Frolov I, Weaver SC. Chimeric alphavirus vaccine candidates for chikungunya.. Vaccine 2008 Sep 15;26(39):5030-9.
        doi: 10.1016/j.vaccine.2008.07.054pubmed: 18692107google scholar: lookup
      48. Volkova E, Frolova E, Darwin JR, Forrester NL, Weaver SC, Frolov I. IRES-dependent replication of Venezuelan equine encephalitis virus makes it highly attenuated and incapable of replicating in mosquito cells.. Virology 2008 Jul 20;377(1):160-9.
        doi: 10.1016/j.virol.2008.04.020pubmed: 18501401google scholar: lookup
      49. Aguilar PV, Leung LW, Wang E, Weaver SC, Basler CF. A five-amino-acid deletion of the eastern equine encephalitis virus capsid protein attenuates replication in mammalian systems but not in mosquito cells.. J Virol 2008 Jul;82(14):6972-83.
        doi: 10.1128/JVI.01283-07pubmed: 18480443google scholar: lookup
      50. Aguilar PV, Adams AP, Wang E, Kang W, Carrara AS, Anishchenko M, Frolov I, Weaver SC. Structural and nonstructural protein genome regions of eastern equine encephalitis virus are determinants of interferon sensitivity and murine virulence.. J Virol 2008 May;82(10):4920-30.
        doi: 10.1128/JVI.02514-07pubmed: 18353963google scholar: lookup
      51. Ilkow CS, Mancinelli V, Beatch MD, Hobman TC. Rubella virus capsid protein interacts with poly(a)-binding protein and inhibits translation.. J Virol 2008 May;82(9):4284-94.
        doi: 10.1128/JVI.02732-07pubmed: 18305028google scholar: lookup
      52. Atasheva S, Garmashova N, Frolov I, Frolova E. Venezuelan equine encephalitis virus capsid protein inhibits nuclear import in Mammalian but not in mosquito cells.. J Virol 2008 Apr;82(8):4028-41.
        doi: 10.1128/JVI.02330-07pubmed: 18256144google scholar: lookup
      53. Garmashova N, Atasheva S, Kang W, Weaver SC, Frolova E, Frolov I. Analysis of Venezuelan equine encephalitis virus capsid protein function in the inhibition of cellular transcription.. J Virol 2007 Dec;81(24):13552-65.
        doi: 10.1128/JVI.01576-07pubmed: 17913819google scholar: lookup